Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th
Streamex (NASDAQ:BSGM), a gold tokenization infrastructure company, announced its participation in the upcoming 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Streamex (NASDAQ:BSGM), a gold tokenization infrastructure company, announced its participation in the upcoming 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th, 2025. The company, which recently merged with BioSig Technologies, will be represented by CEO Henry McPhie and CIO Mitch Williams, who will conduct one-on-one meetings with institutional investors during the conference.
Details
News Market Reaction – BSGM
On Aug 28, the day this news came out, BSGM closed 2.93% above the previous close.
Data tracked by StockTitan Argus for the Aug 28 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LOS ANGELES, CA & VANCOUVER, BC , Aug. 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), a gold tokenization infrastructure company building the foundation for on-chain gold markets, today announced that it will participate in the 5th annual Needham Virtual Crypto 1x1 Conference on September 4th, 2025. BioSig and Streamex CEO, Henry McPhie and CIO, Mitch Williams will host one on one meetings with institutional investors at the conference.
About Streamex
Streamex is an RWA and gold tokenization company building Institutional grade infrastructure to bring the gold market on chain, enabled by a gold denominated treasury and tokenization technology powering the gold market of tomorrow. Streamex is a wholly owned subsidiary of BioSig Technologies, Inc.
About BioSig Technolgies
BioSig Technologies, Inc. is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias.
Contacts BioSig/Streamex Press & Investor Relations: Adele Carey Alliance Advisors Investor Relations acarey@allianceadvisors.com Henry McPhie CEO of BioSig, Co-Founder of Streamex IR@Biosigtech.com contact@Streamex.com https://www.streamex.com/ https://x.com/streamex
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.